News
DOJCivil settlementJanuary 14, 2025NJ

Pharmacy Agrees To Resolve False Claims Act Allegations For Billing For Drugs Not Dispensed

Department of Justice, U.S. Attorney's Office, New Jersey. Published January 14, 2025.

What the release says

From January 1, 2019, through January 24, 2022, Medsinbox caused the submission of claims to Medicare Part D and New Jersey Medicaid for drugs that were never dispensed to beneficiaries.

Programs Medicare, MedicaidOrdered $625K
The release, as published

NEWARK, N.J. to Medsinbox Pharmacy LTC LLC d/b/a Farmacia San Antonio (“Medsinbox”), a pharmacy located in Camden, New Jersey, has agreed to pay $625,000 to resolve allegations that it violated the False Claims Act by knowingly billing federal health care programs for medications that it never dispensed, Acting U.S. Attorney Vikas Khanna announced today. According to the contentions of the United States in the settlement agreement: The United States alleged that, from January 1, 2019, through January 24, 2022, Medsinbox caused the submission of claims for reimbursement to the Medicare Part D Program and the New Jersey Medicaid Program for drugs that were never dispensed to beneficiaries. The government contends that inventory records showed that Medsinbox did not purchase enough of these medications from wholesalers to fill all the prescriptions billed to these federal health care programs. “Pharmacies play an important role in maintaining the safety and accuracy of prescribed medications, and allegedly billing for medications not actually dispensed undermines that role and defrauds our healthcare programs. The government will continue to pursue entities that engage in fraud and abuse at the taxpayers’ expense.” Acting U.S. Attorney Vikas Khanna “Health care providers defraud federal health care programs when they bill for goods or services that they did not provide,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division. “We will hold accountable those who improperly seek to profit from taxpayer funded programs.” The resolution obtained in this matter was the result of a coordinated effort between the U.S. Attorney’s Office for the District of New Jersey and the Justice Department’s Civil Division’s Commercial Litigation Branch, Fraud Section. The government is represented by Assistant U.S. Attorneys Robert Toll and Kruti Dharia of the Opioid Abuse Prevention and Enforcement Unit and Senior Trial Counsel Jennifer Cihon in the Civil Division’s Commercial Litigation Branch (Fraud Section). The government’s pursuit of these matters illustrates the government’s emphasis on combating healthcare fraud. One of the most powerful tools in this effort is the False Claims Act. Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement can be reported to the Department of Health and Human Services, at 1-800-HHS-TIPS (800-447-8477). The claims resolved by the settlements are allegations only, and there has been no determination of liability.

medsinbox.settlement_agreement.pdf

Read the original at justice.govA United States government work, reproduced here so it can be read beside the evidence. Verity adds nothing to it.